Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Weikert

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Deutsches Arzteblatt International|March 30, 2017
In ReplyChristian Doehn, Steffen Weikert
World Journal of Urology|April 15, 2010
Contemporary epidemiology of renal cell carcinoma: perspectives of primary preventionSteffen Weikert, Börje Ljungberg
European Urology|October 25, 2012
Reply from authors re: Camillo Porta, Chiara Paglino. Experience gathered from retrospective series on renal cell carcinoma is useful, but now it is time for a global claim for academically driven prospective studies. Eur Urol 2013;64:71-2: are retrospective data of any value to the specialist treating renal cell carcinoma?Steffen Weikert, Viktor Grünwald
JAMA|March 2, 2006
Urine telomerase and bladder cancer detectionSteffen Weikert, Frank Christoph, Kurt Miller
The New England Journal of Medicine|November 5, 2010
Adverse events associated with testosterone administrationCornelia Weikert, Tobias Pischon, Steffen Weikert
International Journal of Andrology|May 14, 2004
Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patientsSteffen Weikert, Mark Schrader, Markus Müller, et al.
Urologia Internationalis|January 27, 2020
A Stent for Every Stone? Prestenting Habits and Outcomes from a German Multicenter Prospective Study on the Benchmarks of Ureteroroscopic Stone Treatment (BUSTER)Peter Werthemann, Steffen Weikert, Thomas Enzmann, et al.
Health Policy (Amsterdam, Netherlands)|May 19, 2005
Paper tigers--do clinical guidelines improve health care quality in patients with testicular germ cell tumors in Germany?Mark Schrader, Lothar Weissbach, Steffen Weikert, et al.
Fertility and Sterility|April 16, 2005
Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failureSteffen Weikert, Mark Schrader, Markus Müller, et al.
International Journal of Cancer|March 12, 2005
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosisSteffen Weikert, Frank Christoph, Mark Schrader, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Deutsches Arzteblatt International|March 30, 2017
In ReplyChristian Doehn, Steffen Weikert
World Journal of Urology|April 15, 2010
Contemporary epidemiology of renal cell carcinoma: perspectives of primary preventionSteffen Weikert, Börje Ljungberg
European Urology|October 25, 2012
Reply from authors re: Camillo Porta, Chiara Paglino. Experience gathered from retrospective series on renal cell carcinoma is useful, but now it is time for a global claim for academically driven prospective studies. Eur Urol 2013;64:71-2: are retrospective data of any value to the specialist treating renal cell carcinoma?Steffen Weikert, Viktor Grünwald
JAMA|March 2, 2006
Urine telomerase and bladder cancer detectionSteffen Weikert, Frank Christoph, Kurt Miller
The New England Journal of Medicine|November 5, 2010
Adverse events associated with testosterone administrationCornelia Weikert, Tobias Pischon, Steffen Weikert
International Journal of Andrology|May 14, 2004
Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patientsSteffen Weikert, Mark Schrader, Markus Müller, et al.
Urologia Internationalis|January 27, 2020
A Stent for Every Stone? Prestenting Habits and Outcomes from a German Multicenter Prospective Study on the Benchmarks of Ureteroroscopic Stone Treatment (BUSTER)Peter Werthemann, Steffen Weikert, Thomas Enzmann, et al.
Health Policy (Amsterdam, Netherlands)|May 19, 2005
Paper tigers--do clinical guidelines improve health care quality in patients with testicular germ cell tumors in Germany?Mark Schrader, Lothar Weissbach, Steffen Weikert, et al.
Fertility and Sterility|April 16, 2005
Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failureSteffen Weikert, Mark Schrader, Markus Müller, et al.
International Journal of Cancer|March 12, 2005
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosisSteffen Weikert, Frank Christoph, Mark Schrader, et al.
Pageof 10